Parlati Francesco 4/A
4/A · Calithera Biosciences, Inc. · Filed Mar 6, 2018
Insider Transaction Report
Form 4/AAmended
Parlati Francesco
VP, RESEARCH
Transactions
- Exercise/Conversion
Common Stock
2018-02-20$0.96/sh+1,979$1,900→ 25,339 total - Exercise/Conversion
Common Stock
2018-02-20$0.96/sh+3,116$2,991→ 28,455 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-02-20−1,979→ 0 totalExercise: $0.96Exp: 2023-05-22→ Common Stock (1,979 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-02-20−3,116→ 0 totalExercise: $0.96Exp: 2023-05-22→ Common Stock (3,116 underlying)
Footnotes (4)
- [F1]7,967 shares were omitted from the Reporting Person's original Form 4, and also were omitted from the Reporting Person's Form 3 filed by the Reporting Person prior to the date the original Form 4 was filed.
- [F2]Includes 973 and 2,038 shares acquired under the Company's 2014 Employee Stock Purchase Plan on June 9, 2017 and December 8, 2017, respectively.
- [F3]1/48th of the Option vests in equal monthly installments beginning November 15, 2012. The Option shall be subject to accelerated vesting as set fourth in the optionee's employment agreement with the Company.
- [F4]1/48th of the Option vests in equal monthly installments one month after May 23, 2013. The Option shall be subject to accelerated vesting as set fourth in the optionee's employment agreement with the Company.